Joe Romano – Partner
781-279-1320 x 208
QuantumSphere Unveils World’s First Pure Magnetic Nanopowder for Biomedical and Magnetic Resonance Imaging (MRI) Applications
Magnetic Nanopowders Significantly Advance Medical Diagnostic Results Previously Undetectable Using Conventional Technology
COSTA MESA, CA, U.S.A. –March 16, 2005— QuantumSphere today announced that it has unveiled the first pure magnetic nanopowder for biomedical applications. QuantumSphere produces, manufactures and sells magnetic nanopowder based on a material that is not harmful to the body. QuantumSphere’s magnetic nanopowder will be used to dramatically enhance Magnetic Resonance Imaging (MRI) applications. MRI technology can be leveraged in conjunction with QuantumSphere’s magnetic nanoparticles to focus electromagnetic energy waves into the body to view internal organs better, such as the liver, to see damage, or investigate the functions of internal organs. QuantumSphere’s magnetic nanopowders offer orders-of-magnitude performance improvements when compared to existing imaging materials, such as gadolinium dies, and other standard materials used today. Entities such as General Electric, Walter Reed Army Medical Center, and leading academic institutions such as the Mayo Clinic can significantly benefit from this advance.
“QuantumSphere’s introduction of magnetic nanopowders, backed by our mass-scale manufacturing and production capability, marks a milestone in the evolution of science, research and patient treatment. By leveraging our magnetic nanopowders, research institutions and companies alike will enjoy orders-of-magnitude performance improvements in MRI resolution and imaging, better diagnoses and patient treatment,” said Dr. Douglas Carpenter, Chief Scientific Officer and Director of Research and Development, QuantumSphere, Inc. “QuantumSphere’s metallic nanopowders enable users to leverage cutting-edge technology that vastly improves the understanding of disease and organ function. The use of our product will ignite awareness and advances in the MRI field as our nanopowders offer a breakthrough technology that will drive new discoveries and patient analysis. Although the MRI field is a multi-billion market, MRIs use materials such as gadolinium dies or other processes that fail to produce the most efficient number of resolutions to scans and signal to noise ratios. Our technology will solve these issues,” Dr. Carpenter concluded.
QuantumSphere is the leading manufacturer of metallic nanopowders for applications in the aerospace, defense, energy, biomedical and other markets demanding advanced material applications. QuantumSphere enables order-of-magnitude performance improvements for applications by using nanotechnology in existing materials to make new, revolutionary products. QuantumSphere is uniquely positioned to meet the market needs, as the firm’s facility scales up to produce 2,500 pounds of the world’s purest nanopowders, including nanonickel, a month.
About QuantumSphere, Inc.
QuantumSphere is the leading manufacturer of metallic nanopowders for applications in the aerospace, defense, energy, biomedical and other markets demanding advanced material applications. QuantumSphere’s exclusive manufacturing process provides: consistent, narrow particle size distribution; low level of agglomeration and impurities; custom-tailored oxide shell thickness; and the highest purity metallic nanopowders on the market that are easier to transport and handle. The company manufactures the highest quality of metallic nanopowder in the industry without compromising its commitment to the environment. No other company offers these performance advantages.
QuantumSphere is the only supplier of the world’s highest quality nanonickel (n-Ni). This will replace platinum as the main catalyst in hydrogen fuel cells and provide a renewable source of power to supply the world’s energy needs. The company is leveraging its leading market position in nanonickel (n-Ni) to manufacture and ship product for applications in fuel cells, magnetic medical products (e.g., contrast agent that is orders-of-magnitude more sensitive than existing materials for MRI detection of disease and organ function), and other applications including additives for plastics and electromagnetic frequency shielding applications.
For more information, visit www.qsinano.com or contact Joe Romano, Partner, HighGround, Inc. at 781-279-1320 x 208 or [email protected]